Cognetivity Neurosciences Income Statement

Financials in millions CAD. Fiscal year is February - January.

Millions CAD. Fiscal year is Feb - Jan.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Oct '23 Oct 31, 2023	Jan '23 Jan 31, 2023	Jan '22 Jan 31, 2022	Jan '21 Jan 31, 2021	Jan '20 Jan 31, 2020	Jan '19 Jan 31, 2019
Revenue	0.1	0.05	-	-	-	-
Cost of Revenue	1.36	2.18	4.02	1.12	0.42	0.33
Gross Profit	-1.27	-2.13	-4.02	-1.12	-0.42	-0.33
Selling, General & Admin	2.54	3.17	4.79	1.13	1.61	2.16
Research & Development	0	0.6	0.49	0.07	0.49	0.73
Operating Expenses	2.99	4.19	8.98	1.29	2.12	3.77
Operating Income	-4.26	-6.32	-13	-2.4	-2.54	-4.09
Interest Expense	-4.55	-1.03	-0.06	-0.06	-0.06	-
Interest & Investment Income	-	-	-	-	-	0.02
Currency Exchange Gain (Loss)	-0.07	-0.09	-0.02	0.01	0	-0
Other Non Operating Income (Expenses)	0.05	0.02	-0.03	0.53	-0.06	-0.12
EBT Excluding Unusual Items	-8.83	-7.42	-13.12	-1.93	-2.66	-4.19
Gain (Loss) on Sale of Assets	0	0	-0	-	-	-
Asset Writedown	-0.02	-0.02	-	-	-	-
Other Unusual Items	0.07	-	-0.01	0.01	-	-
Pretax Income	-8.64	-7.43	-13.13	-1.93	-2.66	-4.19
Income Tax Expense	-	-	-	0	-0.02	-
Net Income	-8.64	-7.43	-13.13	-1.93	-2.65	-4.19
Net Income to Common	-8.64	-7.43	-13.13	-1.93	-2.65	-4.19
Shares Outstanding (Basic)	90	85	73	59	46	40
Shares Outstanding (Diluted)	90	85	73	59	46	40
Shares Change (YoY)	19.71%	16.41%	24.51%	28.68%	12.83%	36.73%
EPS (Basic)	-0.10	-0.09	-0.18	-0.03	-0.06	-0.10
EPS (Diluted)	-0.10	-0.09	-0.18	-0.03	-0.06	-0.10
Free Cash Flow	-3.86	-5.97	-3.28	-1.98	-1.88	-3.51
Free Cash Flow Per Share	-0.04	-0.07	-0.04	-0.03	-0.04	-0.09
Operating Margin	-4302.88%	-13920.66%	-	-	-	-
Profit Margin	-8732.77%	-16386.31%	-	-	-	-
Free Cash Flow Margin	-3895.12%	-13150.45%	-	-	-	-
EBITDA	-4.23	-6.29	-12.98	-2.39	-2.53	-4.09
D&A For EBITDA	0.03	0.02	0.02	0.01	0.01	0
EBIT	-4.26	-6.32	-13	-2.4	-2.54	-4.09

Updated Dec 29, 2023. Source: S&P Global Market Intelligence. Standard template. Financial Sources.